Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Assessment of Functional Results after Percutaneous Transluminal Coronary Angioplasty by Cardiopulmonary Exercise Test

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Twenty-nine patients with documented coronary artery disease underwent cardiopulmonary exercise tests before and following a percutaneous transluminal coronary angioplasty (PTCA). The patients medication regimen and exercise protocols remained the same in both cases. Following PTCA, significant improvement (p < 0.001–0.0001) was noted in oxygen consumption (1,526.8 ± 470.0 vs. 1,686.2 ± 390 ml/min), oxygen pulse (12.40 ± 2.73 vs. 13.44 ± 2.9 ml/beat), oxygen pulse score (7.62 ± 1.29 vs. 8.85 ± 1.26 points) and in the ventilatory anaerobic threshold (993.1 ± 177.6 vs. 1,089.8 ± 150.9 ml/min) but not (p > 0.05) in maximal heart rate (128.7 ± 16.9 vs. 132.0 ± 17.2 beats/min). Thus, a cardiopulmonary exercise test is an effective method to assess functional results following PTCA.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1998
          May 1998
          29 October 2008
          : 89
          : 4
          : 257-262
          Affiliations
          a Mishmar Hayarden Cardiac and Rehabilitation Institute, Givatayim, and b Exercise Physiology Unit of Pulmonary and Cardiology Departments, Rabin Medical Center, Beilinson Campus, Petah Tiqva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
          Article
          6797 Cardiology 1998;89:257–262
          10.1159/000006797
          9643272
          © 1998 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Figures: 1, Tables: 4, References: 18, Pages: 6
          Categories
          Catheterization and Interventional Cardiology

          Comments

          Comment on this article